Hemi-tibial plateau osteotomy versus high tibial osteotomy with arthroscopic medial meniscus posterior root repair
Official title: Hemi-tibial Plateau Osteotomy Combined With Arthroscopic Repair for Medial Meniscus Posterior Root Tears in Varus Knees: A Single-center, Randomized, Controlled, Open-label, Non-inferiority Study
Run by Eighth Affiliated Hospital, Sun Yat-sen University · NCT07356674 · Data updated 2026-11-12
This study tests whether a newer hemi-tibial plateau osteotomy plus arthroscopic meniscus repair helps people with varus-aligned knees and medial meniscus posterior root tears improve more than the standard high tibial osteotomy plus repair.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 35 Years to 75 Years |
| Sex | All |
| Enrollment | 20 (estimated) |
| Sponsor | Eighth Affiliated Hospital, Sun Yat-sen University Academic / other |
| Locations | 1 site (Shenzhen, Guangdong) |
| Status | Recruiting |
| Started | March 1, 2026 |
| Main results expected | December 31, 2028 |
| Study ends | December 31, 2028 |
| Registry record updated | May 4, 2026 |
| Trial ID | NCT07356674 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 35–75 with varus knee deformity predominantly from the tibia (varus angle <10° and medial proximal tibial angle <87°), MRI-confirmed medial meniscus posterior root tear, medial joint space narrowing with Kellgren-Lawrence grade < IV, and persistent symptoms after at least one month of conservative treatment.
✕Probably not a fit
Patients with advanced knee osteoarthritis (Kellgren-Lawrence grade IV), large varus deformities (≥10°), tears that are not posterior root lesions, or those unable/unwilling to undergo surgery or follow-up are unlikely to benefit from the procedures tested here.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This single-center, randomized surgical comparison will enroll about 20 patients with varus knee alignment and MRI-confirmed medial meniscus posterior root tears. Participants will be randomized to either hemi-tibial plateau osteotomy combined with arthroscopic repair or standard high tibial osteotomy combined with arthroscopic repair. The primary clinical outcome is change in Lysholm knee function score at 12 months, with secondary outcomes including pain, imaging findings, meniscal healing, complications, length of hospital stay, and preliminary cost data. Safety and hospital-related costs will be tracked alongside clinical and imaging outcomes.
Why it matters
Potential benefit: If successful, the newer procedure could provide better knee function and pain relief while promoting meniscal healing and possibly shortening hospital stay or lowering short-term costs.
How similar studies have gone: High tibial osteotomy combined with meniscal repair has supporting prior data, while hemi-tibial plateau osteotomy is a newer variation with limited published evidence.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age 35 to 75 years, with no restriction on sex. * Clinical features suggestive of a medial meniscus posterior root tear, including at least one of the following symptoms: knee locking, clicking, or medial knee pain; and at least one of the following signs: medial joint line tenderness or a positive McMurray test. * Varus knee deformity with a varus angle of less than 10 degrees, with the deformity predominantly originating from the tibia (i.e., medial proximal tibial angle less than 87 degrees). * Knee MRI demonstrates a medial meniscus posterior root tear. * Knee radiographs show narrowing of the medial joint space, and Kellgren-Lawrence grade less than IV. * Failure of conservative treatment (e.g., rest, medication, or physical therapy) for more than 1 month. * Willing to accept randomization and able to understand and sign the informed consent form. * For participants with bilateral deformity, the more severely deformed side will be selected as the operative (study) side. Exclusion Criteria: * Chronic knee locking (e.g., the participant cannot bend or fully straighten the knee). * Kellgren-Lawrence grade IV knee osteoarthritis. * Osteoarthritis or other conditions in other joints (e.g., hip or ankle) that may affect assessment of knee function. * Known inflammatory diseases or other conditions that may affect knee function, including but not limited to: autoimmune diseases (e.g., rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, systemic lupus erythematosus); crystal-induced arthritis (gout, pseudogout); secondary knee osteoarthritis due to trauma or other diseases; active knee joint infection or a history of knee joint infection; reactive arthritis; systemic cartilage disorders; systemic connective tissue diseases; metabolic bone disease; fracture (acute or subacute fracture within 6 months prior to the screening visit); osteonecrosis; or abnormal inflammatory markers (C-reactive protein or high-sensitivity C-reactive protein at least 2 times the upper limit of normal, or erythrocyte sedimentation rate at least 3 times the upper limit of normal), if judged by the investigator to be unsuitable for participation. * Target-knee instability (including but not limited to post-traumatic or congenital laxity) or inadequate ligament reconstruction, as judged by the investigator. * Any prior surgery on the target knee or on other joints of the ipsilateral lower limb. * Serious cardiac disease; hepatic impairment (aspartate aminotransferase or alanine aminotransferase at least 3 times the upper limit of normal, or total serum bilirubin at least 1.5 times the upper limit of normal); renal impairment (serum creatinine at least 1.5 times the upper limit of normal); other musculoskeletal disorders; malignancy; coagulation disorders; immunodeficiency; or psychiatric disorders, if judged by the investigator to be unsuitable for participation. * Body mass index at least 30 kg/m². * Pregnant or breastfeeding women, or participants (including men and women) unwilling to use contraception during the study period. * Participation in another clinical study within 3 months prior to enrollment (excluding registry studies). * Any other condition that, in the investigator's judgment, makes the participant unsuitable for participation.
Where it's running
-
The Eighth Affiliated Hospital, Sun Yat-Sen University
Shenzhen, Guangdong, China Recruiting
Study contacts
- Study coordinator: Hanting Yi
- Email: yiht6@mail2.sysu.edu.cn
- Phone: 852-52091055
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
NPT Feasibility in Knee Osteoarthritis
This study tests whether NRPT can be safely given to adults with knee osteoarthritis and whether it shows early signals of benefit.
-
Aquatic exercise for knee osteoarthritis and central sensitization
A water-based exercise program is being tested to see if it helps people aged 40–65 with knee osteoarthritis who also have central sensitization.
-
Gender-based test of a graded weight-bearing physiotherapy for knee osteoarthritis
We’re testing a 6-week, sensory-modulated graded weight-bearing physiotherapy to see if outcomes differ between men and women with knee osteoarthritis.
-
Does implant type affect knee alignment when using KUNWU robotic surgery
This trial tests whether two knee implants (Attune vs Persona) used with the KUNWU robotic system result in more accurate knee alignment after total knee replacement.
-
Outpatient physiotherapy vs. mHealth exercise and self-management for knee osteoarthritis
This study tests whether a mobile app–guided, self-managed knee OA exercise program is as good as traditional hospital-based therapy for improving walking speed in adults with knee OA.
-
Digital Rehab Program for knee OA using multisensory gear and digital twin tech
A digital rehabilitation program with a smart knee brace and real-time feedback is tested to help adults with knee OA improve movement and function at home.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.